Parvulus Suisse SA Receives CE Mark for its Novel Intra-annular Annuloplasty Ring

(Lonay, Switzerland) 19th December 2011 - Parvulus Suisse SA announced today that it has received a CE Mark for its Intra-annular Ring. Parvulus will launch the device on to the market immediately making the Ring available to cardiac surgeons from January 3rd 2012.

The Intra-annular Ring is indicated for the reinforcement or repair of the human cardiac mitral or tricuspid valves and the treatment of valve insufficiency. It is the only annuloplasty ring that can be utilised in children because it does not constrict the growth of the annulus as the child matures and can be implanted quickly & easily (inside the annular segment) by either; an open, thoroscopic or robotic procedure, avoiding contact with blood and the subsequent use of anti-coagulation therapy.

“We are delighted to have achieved this critical milestone, and to be able to make the Intra-annular Ring available to surgeons throughout Europe and parts of Asia” said Dr. Jason Loveridge, Chief Executive Officer of Parvulus Suisse SA.

Parvulus Suisse SA was established in early 2011 with significant financial backing from Edmond de Rothschild Investment Partners.

For more information please contact Dr. Jason Loveridge.

d’Etraz 2 – CP 8 CH - 1027 Lonay Switzerland

tel. +41 21 802 1163

fax +41 21 802 1165

info@parvulus-suisse.com

www.parvulus-suisse.com

Back to news